跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OMNIC 0,4 mg CAPSULAS DE LIBERACION MODIFICADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OMNIC 0,4 mg CAPSULAS DE LIBERACION MODIFICADA
Approved
STANDARD
OMNIC 0,4 mg CAPSULAS DE LIBERACION MODIFICADA
Astellas Pharma Sp. Z O.O.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 3, 2024
Approval ID
fd13e1d71fda5339
Company
Astellas Pharma Sp. Z O.O.
Type
Standard
Approval Details
Approval Id
fd13e1d71fda5339
Drug Cima Aemps Name
OMNIC 0,4 mg CAPSULAS DE LIBERACION MODIFICADA
Register Number
7164IP
Holder Company Name
Astellas Pharma Sp. Z O.O.
Marketing Company Name
Difarmed S.L.U.
Authorization Date
2024-06-03
Dosage Form
CÁPSULA DURA DE LIBERACIÓN MODIFICADA
Dose
0,4 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Astellas Pharma Sp. Z O.O.
Active Ingredients
TAMSULOSINA HIDROCLORURO
0,4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 3, 2024
Approval ID
fd13e1d71fda5339
Type
Standard
Back to CIMA-AEMPS Approvals
